Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives ...

Molecular Therapy is the official journal of the American Society for Gene & Cell Therapy. Available in print and online, Molecular Therapy is dedicated to publishing important peer-reviewed ...

With the rapid development of antibiotics in the 1930s, phage therapy—using viruses known as bacteriophages or phages to ...

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a clinical-stage biopharmaceutical company that specializes in gene therapy ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver ...

Discover a recent clinical trial that explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...

Matthew Caufield’s rating is based on several promising developments in 4D Molecular Therapeutics’ pipeline. The company’s lead gene therapy product, 4D-150, is showing potential in revolutionizing ...

Physical therapy's benefits were seen without brain stimulation, but remained significant months later in those who got brain stimulation.

A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.5, a high estimate of $39.00, ...

Begin your TipRanks Premium journey today. 4D Molecular Therapeutics (FDMT) Company Description: 4D Molecular Therapeutics Inc is a development stage precision gene therapy company. It engages in ...